Cerebrolysin Neuropeptide improves learning and memory in patients with early to moderately severe dementia associated with Alzheimer’s disease and Post Traumatic Brain Disorder.
Posted on: November 14, 2019 in Category: Cerebrolysin Neuropeptide
2 min read
Does the Cerebrolysin Neuropeptide reverse the pathological changes that cccur in Alzheimer’s disease?
Alzheimer’s disease does occur in some patients with Type 2 Diabetes. Actually, Alzheimer’s disease is thought to be a form of “Type 3 Diabetes” of the brain. Alzheimer’s disease affects the hippocampus, the area of the brain responsible for memory and cognition. Type 2 Diabetic patients with hyperglycemia are prone to develop decreased cognitive performance, loss of memory along with hippocampal atrophy.
This neuronal loss from pro inflammatory AGE’s associated with hyperglycemic events, leads to cognitive decline and poor memory performance. Specifically, there is a loss of neurotransmitters in the hippocampus as well as the axons and dendritic architecture responsible for cognitive performance and memory.
Cerebrolysin’s (CBL) nerve growth factors (NGF) and brain derived neurotrophic like growth factors (BDNF) are thought to halt the autoimmune activation associated with Alzheimer’s disease while promoting hippocampal neurogenesis. CBL also reduces T-lymphocyte induced mediated apoptosis that is associated with neuroinflammation.
Cerebrolysin enhances neurogenesis in the hippocampal subgranular zone of the dentate gyrus by augmenting survival of the neuroprogenitor cells which will improve both learning and memory in patients with Alzheimer’s disease.
Alzheimer’s disease, post traumatic brain disorders, neurodegenerative diseases like multiple sclerosis and Parkinson’s disease have shown improvement in symptoms with the use of Cerebrolysin Neuropeptide.
The pathophysiology of all these neural diseases are similar. There is a cascade of neuroinflammation and apoptosis that Cerebrolysin interrupts while also promoting neurogenesis and neuroregenerative capacity.
At the Sand Institute, you will learn more about Cerebrolysin Neuropeptide and how it may be of benefit in improving your cognitive performance, memory, and learning skills.